Richard T Hinkle Selected Research

Ro 25-1553

2/2005

Activation of the vasoactive intestinal peptide 2 receptor modulates normal and atrophying skeletal muscle mass and force.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Richard T Hinkle Research Topics

Disease

8	Atrophy 01/2011 - 05/2002
2	Hypertrophy 01/2011 - 05/2002
1	Atrophic Muscular Disorders 01/2011
1	Muscle Weakness 01/2011
1	Chronic Disease (Chronic Diseases) 01/2011
1	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 07/2007
1	Wasting Syndrome (Wasting Disease) 12/2005

Drug/Important Bio-Agent (IBA)

2	Corticotropin-Releasing HormoneIBA 07/2006 - 01/2005
2	UrocortinsIBA 07/2006 - 11/2003
2	Adrenal Cortex Hormones (Corticosteroids)IBA 02/2005 - 10/2003
1	SK&F 81297IBA 01/2011
1	Dopamine (Intropin)FDA LinkGeneric 01/2011
1	Adrenocorticotropic Hormone (ACTH)FDA Link 01/2011
1	DystrophinIBA 07/2007
1	Phosphodiesterase 4 InhibitorsIBA 12/2005
1	Type 4 Cyclic Nucleotide PhosphodiesterasesIBA 12/2005
1	Ro 25-1553IBA 02/2005
1	sauvagineIBA 01/2005
1	Adrenergic beta-Agonists (beta-Adrenergic Agonists)IBA 05/2002
1	ClenbuterolIBA 05/2002

Therapy/Procedure

2	Denervation 02/2005 - 05/2002
1	Therapeutics 01/2011